| Literature DB >> 35399493 |
Edoardo Bertero1, Christoph Maack1.
Abstract
Entities:
Year: 2022 PMID: 35399493 PMCID: PMC8991028 DOI: 10.1093/function/zqac012
Source DB: PubMed Journal: Function (Oxf) ISSN: 2633-8823
Figure 1.The Janus-faced mitochondrial F1Fo-ATP synthase as the master regulator of life and death. The electron transport chain (ETC) receives electrons from NADH and FADH2 to translocate protons (H+) across the inner mitochondrial membran (IMM) to provide the driving force for the F1Fo-ATP synthase to produce ATP. The current studies[3],[6] suggest that in addition to the H+ motive force (∆μH), the even greater K+-motive force (∆μK) is harnessed to drive ATP production at the ATPase. Through its impact on mitochondrial volume, this optimizes ATP production during increased ATP demand. Pathological concentrations of Ca2+ and/or reactive oxygen species (ROS) trigger cyclophilin D (CyPD) binding to the ATPase and thereby the formation of a permeability transition pore (PTP), which can induce cell death[9]. K+ flux via the ATPase is under the control of survival-related protein Inhibitory Factor 1 (IF1), which in turn is regulated by the Bcl-family proteins Bcl-xL and Mcl-1, to constitute a mitochondrial ATP-dependent K+ current (KATP) that protects against PTP opening during ischemia/reperfusion and other stress conditions. Organ protection during ischemia/reperfusion provided by the canonical mKATP activator diazoxide requires IF1. K+ influx via the ATPase is counterbalanced by K+ extrusion via the K+/H+-exchanger (KHE). In addition to the ATPase, also CCDC51 complexing with ABCB8 constitutes functional mKATP[16], but without coupling to ATP production.